Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Retinoblastoma 1

Interventions

Carboplatin 23Etoposide 19Vincristine 16Melphalan 13Filgrastim 13Topotecan 10Granulocyte Colony-Stimulating Factor 9Cyclophosphamide 8Thiotepa 7Cryotherapy 7Peripheral Blood Stem Cell Transplantation 4Mesna 4Drug Therapy 4Doxorubicin 3Busulfan 3Brachytherapy 3Temozolomide 2Radiotherapy 2Platinum Compounds 2Magnetic Resonance Imaging 2Ifosfamide 2Eye Enucleation 2Cisplatin 2Blood Specimen Collection 2trioctyl phosphine oxide 1sargramostim 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1omburtamab I-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Retinoblastoma × Maxitrol × Clear all
NCT02792036 2020-02-20

Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma

St. Jude Children's Research Hospital

Phase 1 Completed
8 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡